Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries.

MLA

Jakubowski, Szczepan, et al. “Clinical Aspects of Reimbursement Policies for Orphan Drugs in Central and Eastern European Countries.” Frontiers in Pharmacology, Mar. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fphar.2024.1369178.

APA

Jakubowski, S., Kawalec, P., Holko, P., Kowalska-Bobko, I., Kamusheva, M., Petrova, G., Draganić, P., Fuksa, L., Männik, A., Ispán, F., Briedis, V., Bianchi, I., Paveliu, M. S., & Tesar, T. (2024). Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries. Frontiers in Pharmacology, 1–13. https://doi.org/10.3389/fphar.2024.1369178

Chicago

Jakubowski, Szczepan, Pawel Kawalec, Przemyslaw Holko, Iwona Kowalska-Bobko, Maria Kamusheva, Guenka Petrova, Pero Draganić, et al. 2024. “Clinical Aspects of Reimbursement Policies for Orphan Drugs in Central and Eastern European Countries.” Frontiers in Pharmacology, March, 1–13. doi:10.3389/fphar.2024.1369178.